News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
Market overviews
Direct comparison of products for laboratory and process: Use the comprehensive market overviews to compare products according to your requirements and obtain further information from suppliers.
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
22-May-2007 - Organon announced that it has now completed recruitment for both pivotal phase IIIa trials for NOMAC/E2, its novel oral contraceptive containing natural estrogen. According to the company, the success means the development program is on track for file submission in 2009. NOMAC/E2 is the first ...
21-May-2007 - Organon, the human health care business unit of Akzo Nobel, and Medarex, Inc. announced that they have entered into a collaborative agreement to develop and potentially commercialize fully human antibody therapeutics for the treatment of cancer and auto-immune disorders, utilizing Medarex's ...
21-Feb-2007 - Organon, the human healthcare business unit of Akzo Nobel and Entelos Inc. announced a two-year extension of their ongoing rheumatoid arthritis (RA) collaboration. Financial terms were not disclosed. "We are very pleased to continue our partnership with Organon," stated James Karis, president ...
15-Feb-2007 - Pharmacopeia and Organon, the human healthcare business unit of Akzo Nobel, announced that they have entered into a new alliance to discover, develop and commercialize therapeutic products across a broad range of therapeutic indications, including neuroscience and immunology. This alliance builds ...
30-Jan-2007 - Diosynth Biotechnology appointed Van Kimmenaede as new president. Van Kimmenaede, who joined Organon in 1986, served as general manager in the UK and in senior management roles in global marketing and manufacturing in Italy, the Netherlands and most recently in New Jersey, USA. On January 1, ...
22-Dec-2006 - Organon, the human healthcare business unit of Akzo Nobel, has moved Org 50081, a Serotonin 2 blocker (S2B) for the treatment of insomnia, into Phase III clinical development. Willem de Laat, executive vice-president medical affairs at Organon said "Investigated dosages of the Org 50081 ...
25-Oct-2006 - Organon, the human health care business unit of Akzo Nobel , and BrainCells Inc. (BCI) announced they will collaborate in the discovery and development of drugs for the treatment of central nervous system (CNS) disorders. BCI will use its proprietary technology in the area of neurogenesis - the ...
05-Sep-2006 - The Irish National Institute for Bioprocessing Research and Training (NIBRT) and Organon, the human healthcare business of Akzo Nobel, announced the formation of a research collaboration which will focus on the control and understanding of glycosylation in CHO cell culture. The collaboration is ...
27-Jul-2006 - Organon announced that it has started phase III clinical studies for Org 36286 (corifollitropin alfa). The Org 36286 LIFE clinical trial program has been designed to evaluate a new regimen for the treatment of infertility. A single injection of Org 36286 will eliminate the need for seven ...
10-Jul-2006 - Akzo Nobel's Nobilon International business, active in the field of human vaccines, has signed a contract with the Netherlands Vaccine Institute (NVI) to jointly develop a vaccine against respiratory syncytial virus (RSV), a viral infection which can prove fatal to young children and the ...
© 1997-2024 LUMITOS AG, All rights reserved